Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Synthetic Biologics Inc. SYN

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The...


Top institutional share ownership of Synthetic Biologics Inc

Name Shares Shares % change Value Value % change
Vanguard Group Inc 5,296,501 0.0% $1,130 -25.2%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 3,308,735 0.0% $706 -25.2%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 1,942,122 0.0% $414 -25.3%
BlackRock Inc. 1,885,693 0.0% $402 -25.3%
Truist Financial Corp 1,200,029 $256
Geode Capital Management, Llc 1,165,836 3.3% $248 -22.7%
FSMAX - Fidelity Extended Market Index Fund 690,119 0.0% $152 -9.5%
State Street Corp 486,920 0.0% $104 -25.2%
Northern Trust Corp 330,792 -1.7% $70 -27.1%
Blair William & Co/il 303,152 17.7% $65 -11.0%

Top institutional buyers of Synthetic Biologics Inc

Name Shares % change Value % change Shares Value
Susquehanna International Group, Llp 109.5% 60.0% 39,345 $8
Renaissance Technologies Llc 103.9% 51.6% 219,000 $47
Two Sigma Securities, Llc 84.8% 36.4% 69,844 $15
Blair William & Co/il 17.7% -11.0% 303,152 $65
Geode Capital Management, Llc 3.3% -22.7% 1,165,836 $248

Top institutional sellers of Synthetic Biologics Inc

Name Shares % change Value % change Shares Value
Landmark Financial Advisors, LLC -5.0% -16.7% 23,000 $5
Two Sigma Advisers, Lp -3.5% -27.5% 135,300 $29
Northern Trust Corp -1.7% -27.1% 330,792 $70
USMIX - Extended Market Index Fund -1.4% -33.3% 22,035 $5
Two Sigma Investments, Lp -1.1% -27.7% 161,373 $34
Victory Capital Management Inc -0.7% 0.0% 22,035 $5

Information provided by Fintel.io